Antigen binding proteins
US11419945B2 · kind B2 · utility
0Cited by
28References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 2020 |
| Grant date | Aug 23, 2022 |
| Priority date | — |
| Expiry date | Jul 13, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns antigen binding proteins and fragments thereof which specifically bind B Cell Maturation Antigen (BCMA), particularly human BCMA (hBCMA) and which inhibit the binding of BAFF and APRIL to the BCMA receptor. Further disclosed are pharmaceutical compositions, screening and medical treatment methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.